Comparison of Species Differences of P-Glycoproteins in Beagle Dog, Rhesus Monkey, and Human Using ATPase Activity Assays-Reference-Cited by-同舟云学术

Comparison of Species Differences of P-Glycoproteins in Beagle Dog, Rhesus Monkey, and Human Using ATPase Activity Assays

Published:2005-12-20 Issue:1 Volume:3 Page:78-86
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Xia Cindy Q.¹,Xiao Guangqing¹,Liu Ning¹,Pimprale Satish¹,Fox Lisa¹,Patten Chris J.¹,Crespi Charles L.¹,Miwa Gerald¹,Gan Liang-Shang¹

Affiliation:

1. Drug Metabolism and Pharmacokinetics, Drug Safety and Disposition, Millennium Pharmaceuticals, Inc., 45 Sidney Street, Cambridge, Massachusetts 02139, and BD Biosciences Discovery Labware, 6 Henshaw Street, Woburn, Massachusetts 01801

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp050034j

Reference34 articles.

1. ABC Transporters: From Microorganisms to Man

2. BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER

3. Impact of Drug Transporter Studies on Drug Discovery and Development

4. Heterogeneity of hepatic microsomal UDP-glucuronosyltransferase(s) activities: Comparison between human and mammalian species activities

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anatomical and Physiological Factors Affecting Oral Drug Bioavailability in Rats, Dogs, Monkeys, and Humans;Oral Bioavailability and Drug Delivery;2023-10-10

2. Characterization of P‐glycoprotein orthologs from human, sheep, pig, dog, and cat;Journal of Veterinary Pharmacology and Therapeutics;2023-05-17

3. Drug discovery: Standing on the shoulders of giants;Managing the Drug Discovery Process;2023

4. The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discovery;Biopharmaceutics & Drug Disposition;2022-10-17

5. Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment;Frontiers in Pharmacology;2022-08-16